In vitro treatment of gastric cancer cell line KKLS, which expresses VEGFR-3, with the ligand of this receptor, VEGF-C, stimulated cell proliferation and increased expression of mRNAs encoding cyclin D1, PlGF, and autocrine motility factor [58]. Here, VEGFC is linked to gastric cancer.